Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020)
Praxis Precision Medicines (PRAX) recorded quarterly Minority Interest of $46.2 million in Q3 2020, down 10.64% quarter-over-quarter from $51.7 million in Q2 2020, and up 373.37% on a YoY basis from $9.8 million in Q4 2019.
Praxis Precision Medicines (PRAX) Minority Interest (2019 - 2020) Analysis & Trends
Praxis Precision Medicines' Minority Interest history runs 2 years deep, the most recent figure standing at $46.2 million for Q3 2020.
- In Q3 2020, Minority Interest rose 373.37% year-over-year to $46.2 million; the TTM figure through Sep 2020 stood at $46.2 million (up 373.37% YoY), while the FY2019 annual figure was $50.0 million, changed N/A from the prior year.
- Minority Interest was $46.2 million for Q3 2020 at Praxis Precision Medicines, down from $51.7 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $51.7 million in Q2 2020 to a low of $9.8 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 46.24 Mn |
| Jun 30, 2020 | 51.75 Mn |
| Dec 31, 2019 | 49.97 Mn |
| Sep 30, 2019 | 9.77 Mn |